Virpax Pharmaceuticals Inc
General ticker "VRPX" information:
- Sector: Health Care
- Industry: Pharmaceuticals
- Capitalization: $1.8M
Virpax Pharmaceuticals Inc does not follow the US Stock Market performance with the rate: -41.7%.
Estimated limits based on current volatility of 4.5%: low 0.32$, high 0.37$
Factors to consider:
- Current price 80.4% below estimated low
- Earnings for 9 months up through Q3 are close to our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-12-31 to 2025-12-30
- 2023-12-31 to 2024-12-30 estimated range: [1.75$, 5.55$]
- 2024-12-30 to 2025-12-30 estimated range: [1.57$, 4.60$]
Financial Metrics affecting the VRPX estimates:
- Negative: Non-GAAP EPS, $ of -13.00 <= 0.10
- Negative: Operating profit margin, % of -100 <= 1.03
- Negative: negative Net income
- Negative: Operating cash flow per share per price, % of -68.92 <= 2.35
- Negative: Industry earnings per price (median), % of -15.01 <= 1.31
- Negative: Industry operating profit margin (median), % of -70.04 <= 2.14
Short-term VRPX quotes
Long-term VRPX plot with estimates
Financial data
YTD | 2021-12-31 | 2022-12-31 | 2023-12-31 |
---|---|---|---|
Operating Revenue | $0.00MM | $0.00MM | $0.00MM |
Operating Expenses | $12.03MM | $21.85MM | $15.69MM |
Operating Income | $-12.03MM | $-21.85MM | $-15.69MM |
Non-Operating Income | $-0.03MM | $0.19MM | $0.50MM |
Interest Expense | $0.09MM | $0.00MM | $0.00MM |
R&D Expense | $4.84MM | $10.76MM | $5.12MM |
Income(Loss) | $-12.06MM | $-21.65MM | $-15.19MM |
Profit(Loss) | $-12.06MM | $-21.65MM | $-15.19MM |
Stockholders Equity | $37.48MM | $16.58MM | $1.93MM |
Assets | $39.57MM | $19.67MM | $9.63MM |
Operating Cash Flow | $-14.54MM | $-17.85MM | $-9.85MM |
Financing Cash Flow | $51.33MM | $0.00MM | $0.00MM |
Earnings Per Share* | $-10.37 | $-18.32 | $-12.97 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.